Literature DB >> 23694772

Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research.

Andreas P Kalogeropoulos1, Vasiliki V Georgiopoulou, Barry A Borlaug, Mihai Gheorghiade, Javed Butler.   

Abstract

Entities:  

Keywords:  heart failure; outcomes; prognosis; pulmonary hypertension; treatment

Mesh：

Year:  2013        PMID： 23694772      PMCID： PMC3662027          DOI： 10.1161/CIRCHEARTFAILURE.112.000096

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  115 in total

1.  Pulmonary artery hypertension in heart transplant recipients: how much is too much?

Authors:  Luca Salvatore De Santo; Gianpaolo Romano; Ciro Maiello; Marianna Buonocore; Mariano Cefarelli; Nicola Galdieri; Gianantonio Nappi; Cristiano Amarelli
Journal:  Eur J Cardiothorac Surg       Date:  2012-03-07       Impact factor: 4.191

2.  Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study.

Authors:  Marco Guazzi; Marco Vicenzi; Ross Arena
Journal:  Eur J Heart Fail       Date:  2011-11-07       Impact factor: 15.534

3.  Clinical and hemodynamic effects of bosentan dose optimization in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension--a multi-center randomized study.

Authors:  Edo Kaluski; Gad Cotter; Marina Leitman; Olga Milo-Cotter; Ricardo Krakover; Isaac Kobrin; Tina Moriconi; Maurizio Rainisio; Avraham Caspi; Leonardo Reizin; Reuven Zimlichman; Zvi Vered
Journal:  Cardiology       Date:  2007-09-17       Impact factor: 1.869

Review 4.  Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective.

Authors:  Mardi Gomberg-Maitland; Christopher Dufton; Ronald J Oudiz; Raymond L Benza
Journal:  J Am Coll Cardiol       Date:  2011-03-01       Impact factor: 24.094

5.  Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).

Authors:  Thomas F Lüscher; Frank Enseleit; Richard Pacher; Veselin Mitrovic; Matthias R Schulze; Roland Willenbrock; Rainer Dietz; Valentin Rousson; David Hürlimann; Sebastian Philipp; Thomas Notter; Georg Noll; Frank Ruschitzka
Journal:  Circulation       Date:  2002-11-19       Impact factor: 29.690

6.  Accuracy of Doppler-derived estimation of pulmonary vascular resistance in congenital heart disease: an index of operability.

Authors:  Gholam Hossein Ajami; Sirous Cheriki; Hamid Amoozgar; Mohammad Borzouee; Manoucher Soltani
Journal:  Pediatr Cardiol       Date:  2011-07-22       Impact factor: 1.655

7.  Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study.

Authors:  Milton Packer; John McMurray; Barry M Massie; Abraham Caspi; Vincent Charlon; Alain Cohen-Solal; Wolfgang Kiowski; William Kostuk; Henry Krum; Barry Levine; Paolo Rizzon; Jordi Soler; Karl Swedberg; Susan Anderson; David L Demets
Journal:  J Card Fail       Date:  2005-02       Impact factor: 5.712

8.  Anti-ischaemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: when does cross-tolerance occur?

Authors:  Marek Antoni Kośmicki; Hanna Szwed; Zygmunt Sadowski
Journal:  Cardiovasc Drugs Ther       Date:  2004-01       Impact factor: 3.727

9.  Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.

Authors:  T Münzel; H Sayegh; B A Freeman; M M Tarpey; D G Harrison
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

10.  Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database.

Authors:  Kiran K Khush; Gudaye Tasissa; Javed Butler; Dana McGlothlin; Teresa De Marco
Journal:  Am Heart J       Date:  2009-04-23       Impact factor: 4.749
View more
  4 in total

Review 1.  Use of Cardiac Imaging to Evaluate Cardiac Function and Pulmonary Hemodynamics in Patients with Heart Failure.

Authors:  Tomoko S Kato; Masao Daimon; Toru Satoh
Journal:  Curr Cardiol Rep       Date:  2019-05-10       Impact factor: 2.931

2.  Improvement of Left Ventricular Ejection Fraction and Pulmonary Hypertension Are Significant Prognostic Factors in Heart Failure with Reduced Ejection Fraction Patients.

Authors:  Hee Jin Kwon; Jae Hyeong Park; Jin Joo Park; Jae Hwan Lee; In Whan Seong
Journal:  J Cardiovasc Imaging       Date:  2019-10

3.  Echocardiographic assessment of pulmonary artery systolic pressure and outcomes in ambulatory heart failure patients.

Authors:  Andreas P Kalogeropoulos; Sarawut Siwamogsatham; Salim Hayek; Song Li; Anjan Deka; Catherine N Marti; Vasiliki V Georgiopoulou; Javed Butler
Journal:  J Am Heart Assoc       Date:  2014-02-03       Impact factor: 5.501

Review 4.  Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction.

Authors:  Rohan Samson; Abhishek Jaiswal; Pierre V Ennezat; Mark Cassidy; Thierry H Le Jemtel
Journal:  J Am Heart Assoc       Date:  2016-01-25       Impact factor: 5.501
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.